Solana Co — Director's Dealing 2018

Jul 11, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2018-07-09

Reporting Person: Laux Jennifer (Chief Commercial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-07-09	Employee Stock Option (right to buy)	$9.69	A	150000	Acquired	2028-07-09	Class A Common Stock (150000)	Direct

Footnotes

F1: Grant to the Reporting Person of a stock option under the Issuer's 2018 Omnibus Incentive Plan. The shares vest over four years, with 25% of the shares vesting on July 9, 2019 and the remaining shares vesting monthly thereafter, subject to the Reporting Person's continued service through each applicable vesting date.